Premarket safety and efficacy studies for ADHD medications in children Publication: Journal Article Bourgeois, Kim, and Mandl. 2014. “Premarket Safety and Efficacy Studies for ADHD Medications in Children”. PLoS One 9: e102249.
Are Meaningful Use Stage 2 certified EHRs ready for interoperability? Findings from the SMART C-CDA Collaborative Publication: Journal Article D’Amore, Mandel, Kreda, Swain, Koromia, Sundareswaran, Alschuler, et al. 2014. “Are Meaningful Use Stage 2 Certified EHRs Ready for Interoperability? Findings from the SMART C-CDA Collaborative”. J Am Med Inform Assoc.
Availability and quality of mobile health app privacy policies Publication: Journal Article Sunyaev, Dehling, Taylor, and Mandl. 2014. “Availability and Quality of Mobile Health App Privacy Policies”. J Am Med Inform Assoc.
Averting the perfect storm: addressing youth substance use risk from social media use. Publication: Journal Article Salimian, Parissa, Rumi Chunara, and Elissa Weitzman. 2014. “Averting the Perfect Storm: Addressing Youth Substance Use Risk from Social Media Use.”. Pediatric Annals 43 (10): 411.
Linking multiple heterogeneous data sources to practice guidelines Publication: Journal Article Wingerde, Sun, Harary, Mandl, Salem-Schatz, Homer, and Kohane. 1998. “Linking Multiple Heterogeneous Data Sources to Practice Guidelines”. Proc AMIA Symp, 391-5.
Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy. Publication: Journal Article Ottenheijm, Coen, Danielle Buck, Josine Winter, Claudia Ferrara, Nicoletta Piroddi, Chiara Tesi, Jeffrey Jasper, et al. 2013. “Deleting Exon 55 from the Nebulin Gene Induces Severe Muscle Weakness in a Mouse Model for Nemaline Myopathy.”. Brain 136 (Pt 6): 1718-31.
Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations. Publication: Journal Article Winter, Josine Marieke, Danielle Buck, Carlos Hidalgo, Jeffrey Jasper, Fady Malik, Nigel Clarke, Ger Stienen, et al. 2013. “Troponin Activator Augments Muscle Force in Nemaline Myopathy Patients With Nebulin Mutations.”. J Med Genet 50 (6): 383-92.
Selenoprotein N deficiency in mice is associated with abnormal lung development. Publication: Journal Article Moghadaszadeh, Behzad, Branden Rider, Michael Lawlor, Martin Childers, Robert Grange, Kushagra Gupta, Steve Boukedes, Caroline Owen, and Alan Beggs. 2013. “Selenoprotein N Deficiency in Mice Is Associated With Abnormal Lung Development.”. FASEB J 27 (4): 1585-99.
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Publication: Journal Article Lawlor, Michael, Dustin Armstrong, Marissa Viola, Jeffrey Widrick, Hui Meng, Robert Grange, Martin Childers, et al. 2013. “Enzyme Replacement Therapy Rescues Weakness and Improves Muscle Pathology in Mice With X-Linked Myotubular Myopathy.”. Hum Mol Genet 22 (8): 1525-38.
Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Publication: Journal Article Ceyhan-Birsoy, Ozge, Pankaj Agrawal, Carlos Hidalgo, Klaus Schmitz-Abe, Elizabeth Dechene, Lindsay Swanson, Rachel Soemedi, et al. 2013. “Recessive Truncating Titin Gene, TTN, Mutations Presenting As Centronuclear Myopathy.”. Neurology 81 (14): 1205-14.